Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04614766
Title A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Tumors (SPORE-3)
Acronym SPORE-3
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors David Bushnell
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.